Chronic Hepatitis C Treatment in Egyptian Children With Gaucher Disease.
Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
This prospective open label study is designed to screen all available Gaucher disease
patients [either on enzyme replacement therapy (ERT) or not] for hepatitis C virus (HCV)
infection. Furthermore to evaluate the safety and effectiveness of combined
Sofosbuvir/Ledipasvir regimen given for 12 weeks in chronically infected patients aged 6-18
years.
Phase:
Phase 4
Details
Lead Sponsor:
Mansoura University Children Hospital
Treatments:
Ledipasvir Ledipasvir, sofosbuvir drug combination Sofosbuvir